Sustained-release microgel ointments with high drug loading and preparation methods and uses thereof
US12318371B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | May 13, 2020 |
| Grant date | Jun 3, 2025 |
| Priority date | — |
| Expiry date | Sep 25, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P17/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a sustained-release microgel ointment with high drug loading and a preparation method and use thereof. HTCC aqueous solution and HA aqueous solution are mixed uniformly to obtain the microgel aqueous solution. A drug is mixed with the microgel aqueous solution and concentrated, and a thickening agent is added and mixed evenly to obtain the sustained-release microgel ointment with high drug loading. The HA and HTCC form a microgel through electrostatic action, which is safe and convenient. The concentration step increases the concentration of the drug solution outside the microgel, which can increase the drug loading of the microgel. Drugs not loaded in the microgel inhibited the drug from being released from the microgel, prolonging the sustained release time of the microgel. The thickener transforms the drug-loaded microgel suspension into a paste, facilitating to applying the drug on the skin surface. Meanwhile, the drug added can be used at 100%, reducing the cost of microgel ointment. The ointment can be used to prepare a medicine for treating histamine-independent pruritus and analgesia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.